Description for medicine or protocol of treatment in detail:
|
Prescription composition: Scutellaria baicalensis, honeysuckle, forsythia, artificial bezoar, mother-of-pearl, and the auxiliary material is talcum powder. Functions and indications are to dispel wind and relieve the surface, clear heat and detoxify, and is used for cold and fever, cough and sore throat caused by exogenous wind-heat and internal stagnation of fire.
Treatment plan 1. Medication method Test group: Niuhuang Qinggan capsules, 4 capsules at a time, 3 times a day. Control group: Shufengjiedu capsules, 4 capsules at a time, 3 times a day. Course of treatment: 3 days. The experimental drugs were provided by Heilongjiang Aolidanide Pharmaceutical Co., Ltd. in accordance with the blind method, and the drug test report of the corresponding batch number was also provided. After the end of the trial, the remaining trial drugs will be taken back and destroyed by the sponsor. 2. Concomitant medication and treatment (1) During the observation period, in addition to the prescribed experimental medication, it is forbidden to use other antibacterial and antiviral drugs, or take traditional Chinese medicine or Chinese patent medicine with the functions of dispelling wind, clearing heat, detoxification, and sore throat, or non-steroidal medicine. Body type anti-inflammatory, antipyretic and analgesic drugs; it is forbidden to use acupuncture, scraping, bloodletting, etc. that have a therapeutic effect on colds. (2) Body temperature ≥ 39°C for 2 hours after taking the medicine, or body temperature ≥ 38.5°C for 4 hours after taking the medicine, if there is no contraindication, you can take acetaminophen tablet 0.3g (1 tablet). - Repeat the medication once every 6 hours, not more than 4 times within 24 hours, and record the dosage and time truthfully. If emergency medication is used more than 2 times, stop the trial and seek medical attention in time; (3) For other comorbid diseases, on the premise of not affecting the efficacy and safety of the trial drug, symptomatic medication can be used, but the generic name of the drug or other drugs must be recorded in the case report form. Name of therapy, dosage, reason for use, frequency and time of use, etc., for analysis and reporting when summarizing.
|
Exclusion criteria:
|
(1) Have a confirmed case of influenza, new coronary pneumonia or contact history in an epidemic area within 14 days; (2) Combine any one of the following: herpetic angina, acute pharyngeal conjunctivitis, rhinitis, sinusitis, otitis media, suppurative tonsillitis , bronchiolitis, pulmonary tuberculosis, bronchiectasis or chest X-ray showing pulmonary inflammatory lesions and other diseases; (3) white blood cell count <3.0×109/L or exceeding the upper limit, suspected bacterial infection, or (and) neutrophils The proportion is more than 80%; (4) Complicated with serious primary diseases of the heart, brain, lung, liver, kidney and hematopoietic system; abnormal liver and kidney function ALT, AST ≥ 1.5 times the upper limit of normal; creatinine exceeds the upper limit of normal; (5 ) pregnant, suspected pregnancy, lactating female patients or patients who refused to use contraceptive measures during the study period (including males and females); Chinese medicines or proprietary Chinese medicines with heat-clearing, detoxifying, and throat-relieving effects, or taking nourishing Chinese medicines; taking non-steroidal anti-inflammatory, antipyretic and analgesic drugs within 12 hours; (8) Suspected or actual history of alcohol or drug abuse; (9) Known resistance to experimental drugs or acetaminophen Allergic; (10) Patients who have participated in other clinical trials within three months; (11) Other conditions judged by the investigator or assistant investigator to be inappropriate to participate in the study.
|